Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

RNA expression offers potential biomarker in hemophilia A

Niloofar N et al. Hematology. 2019;24(1):255-62

Publish date:: January 23, 2019

Key clinical point: The expression of long noncoding RNA on the factor VIII gene may help pinpoint the severity of hemophilia A.

Major finding: Transcript levels of two long noncoding RNAs were significantly lower in severe hemophilia A patients, compared with healthy controls (P less than .05).

Study details: An analysis of RNA expression levels in 50 patients with severe hemophilia A and 50 healthy controls at a single center in Iran.

Disclosures: There was no outside funding for the study, and no potential conflict of interest information was reported by the authors.

Read the article here.

Citation:

Niloofar N et al. Hematology. 2019;24(1):255-62.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,